HPB Parallel Session 1

Thursday, March 21, 2024

2:00pm – 3:30pm ET

Location:C101

Moderator(s)

Syed Ahmad, MD (he/him/his)

Professor of Surgery, Director University of Cincinnati Cancer Center
University of Cincinnati Cancer Center
Cincinnati, Ohio, United States

Disclosure(s): No financial relationships to disclose
Laleh Melstrom, MD

Associate Professor
Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA
La Verne, California, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Syed A. Ahmad, MD: No financial relationships to disclose

Laleh Melstrom, MD: No financial relationships to disclose

Presentations:

2:02pm – 2:12pm ET

42: Salvage Hepatic Artery Infusion Chemotherapy after First Line Systemic Failure in Patients with Unresectable Cholangiocarcinoma
Abstract Presenter: Misha Armstrong, MD MPH (she/her/hers) – New York Presbyterian / Weill Cornell Medicine
Submitter: Misha Armstrong, MD MPH (she/her/hers) – New York Presbyterian / Weill Cornell Medicine
Author: Naaz Nasar, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Joanne Chou, MS – Memorial Sloan Kettering Cancer Center
Author: Mithat Gonen, PhD – Memorial Sloan Kettering Cancer Center
Author: Kevin C. C. Soares, MD – Memorial Sloan Kettering Cancer Center
Author: Vinod P. Balachandran, MD – Memorial Sloan Kettering Cancer Center
Author: Jeffrey A. Drebin, MD, PhD – Memorial Sloan Kettering Cancer Center
Author: T. Peter Kingham, MD – Memorial Sloan Kettering Cancer Center
Author: Alice C. Wei, MD, MS, FRCSC (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Michael I. I. D'Angelica, MD – Memorial Sloan Kettering Cancer Center
Author: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center
Author: James J. J. Harding, MD – Memorial Sloan Kettering Cancer Center
Author: Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center
Author: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
Author: Wungki Park, MD – Memorial Sloan Kettering Cancer Center
Author: Louise Connell, MD – Memorial Sloan Kettering Cancer Center
Author: Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center
Author: William R. R. Jarnagin, MD – Memorial Sloan Kettering Cancer Center
2:12pm – 2:22pm ET

43: An Update On The Phase I Study to Evaluate the Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma
Abstract Presenter: Nicholas A. Ullman, MD – University of Rochester Medical Center
Submitter: Nicholas A. Ullman, MD – University of Rochester Medical Center
Author: Nicholas A. Ullman, MD – University of Rochester Medical Center
Author: Richard Dunne, MD – University of Rochester
Author: Daniel Mulkerin, MD – University of Rochester
Author: Brian Belt, JD – University of Rochester
Author: Luis I. Ruffolo, MD – University of Rochester
Author: Paul R. Burchard, MD – University of Rochester
Author: Matthew Byrne, MD – University of Rochester Medical Center
Author: Mary Georger, MS – University of Rochester
Author: Aram Hezel, MD – University of Rochester
Author: Jason Zittel, MD – University of Rochester
Author: Wenjia Wang, MD – University of Rochester
Author: Erika Ramsdale, MD – University of Rochester
Author: Vivek Kaul, MD – University of Rochester
Author: John Zebala, MD – Syntrix Pharmaceuticals
Author: David Linehan, MD – University of Rochester Medical Center
2:22pm – 2:32pm ET

44: Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC)
Abstract Presenter: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Submitter: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Mary Martos, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Erin M. Dickey, MD, MBS – Department of Surgery, University of Miami Miller School of Medicine
Author: Andres Corona, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Nkiruka Ezenwajiaku, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Joseph Pizzolato, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Gretel Terrero, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Caitlin A. Hester, MD – Division of Surgical Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Cente
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
Author: Peter Hosein, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
2:32pm – 2:42pm ET

45: Postoperative Complications Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)
Abstract Presenter: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Submitter: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Tyler J. Zemla, MS – Alliance Statistics and Data Management Center
Author: Qian Shi, PhD – Alliance Statistics and Data Management Center
Author: Diana Segovia, BS – Alliance Statistics and Data Management Center
Author: Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center
Author: Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center
Author: Joseph M. Herman, MD – Northwell Health Cancer Institute
Author: Matthew H.G Katz, MD (he/him/his) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
2:42pm – 2:52pm ET

46: A novel mechanism of immunotherapy sensitivity following platinum chemotherapy resistance in pancreatic cancer patients with germline homologous recombination deficiency
Abstract Presenter: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Submitter: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Author: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Author: Karthik Rajkumar, PhD – University of Miami
Author: Anna Bianchi, PhD – University of Miami School of Medicine - Miami, FL
Author: Lucas Caeiro, PhD – University of Miami School of Medicine - Miami, FL
Author: Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL
Author: Luis Nivelo, MS – University of Miami School of Medicine - Miami, FL
Author: Iago De Castro Silva, MD – University of South Florida
Author: Andrew Adam, MS – University of Miami School of Medicine - Miami, FL
Author: Vanessa Garrido, PhD – University of Miami School of Medicine - Miami, FL
Author: Samara Singh, BS – University of Miami School of Medicine - Miami, FL
Author: Nagaraj Nagathihalli, PhD – University of Miami School of Medicine - Miami, FL
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
Author: Ramiro Verdun, PhD – University of Miami School of Medicine - Miami, FL
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
2:52pm – 3:02pm ET

47: Chemotherapy Dose Density is Prognostic for Patients with Resectable Pancreas Cancer: A Secondary Analysis of SWOG S1505
Abstract Presenter: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
Submitter: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
Author: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
Author: Sarah Colby, PhD – Fred Hutchinson Cancer Center
Author: Davendra Sohal, MD – University of Cincinnati College of Medicine
Author: Katherine Guthrie, PhD – Fred Hutchinson Cancer Center
Author: Lisa Kachnic, MD – Columbia University Irving Medical Center
Author: Gabriela Chiorean, MD – University of Washington
Author: Andrew M. Lowy, MD – Department of Surgery, Division of Surgical Oncology, University of California, San Diego
Author: Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Philip Philip, MD – Wayne State University Henry Ford Cancer Institute
Author: Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center
3:02pm – 3:12pm ET

48: Highly Sensitive Low Input Methylated Digital Droplet PCR Assay for Pancreatic Adenocarcinoma Molecular Subtyping
Abstract Presenter: Hannah Trembath, MD – University of North Carolina
Submitter: Hannah Trembath, MD – University of North Carolina
Author: Hannah Trembath, MD – University of North Carolina
Author: Ian McCabe, B.S. – University of North Carolina at Chapel Hill
Author: Sandra Zarmer, B.S. – University of North Carolina at Chapel Hill
Author: Zachary Schrank, B.S. – University of North Carolina at Chapel Hill
Author: Hannah Thel, B.S. – University of North Carolina at Chapel Hill
Author: Justin Ashby, B.S. – University of North Carolina at Chapel Hill
Author: Joseph Kearney, M.D. – UNC Hospitals- General Surgery
Author: Yi Xu, B.S. – University of North Carolina at Chapel Hill
Author: Gabriela Herrera, B.S. – University of North Carolina at Chapel Hill
Author: Des Weighill, Ph.D. – University of North Carolina at Chapel Hill
Author: Jen Jen Yeh, MD – University of North Carolina at Chapel Hill
3:12pm – 3:22pm ET

49: A Prospective Evaluation of a Modified Hepatic Arterial Infusion Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases
Abstract Presenter: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Submitter: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Skye C. Mayo, MD MPH (he/him/his) – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
Author: Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Adel Kardosh, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Jillian Paxton, PharmD – OHSU, Department of Pharmacy Services, Portland, OR 97239 USA
Author: Robert Eil, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Emerson Chen, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Emile J. Latour, MS – Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA
Author: Guillaume Pegna, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Charles Lopez, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA